The story relies heavily on anecdotes, and while these personal stories are weighed against the perspectives of outside researchers, with much research being cited, we are never given needed details on what that research contains.
Lacking independent sources and a robust discussion of the study’s limitations, this story was thin on any information not already provided in the news release.
This story fails to counter rosy statements by a physician and a patient with realistic assessments of the potential benefits and pitfalls of an unproven procedure for a fatal disease with no known cure.
For a study as confusing as this one from the New England Journal of Medicine, this brief story does a good job of describing it, as well as some its limitations.
A powerful anecdote obscures information gaps in this story about stroke surgery.
This story had no data, no broader perspective, no independent voices, no pushback at all on the claims made. For readers hopeful to read about a new autism treatment, all of this is important.
Although it’s missing any hard quantitative research data, the story hits a good number of high notes and benchmarks in the “news you can use” category.
The story didn’t discuss the limitations of risk assessments, nor explain or define what “risk” really means. The headline also overstated the scope of the study. These issues–paired with a lack of information on costs and screening harms–add up to an incomplete story.